We restore endothelial cell function.

Get in touch

Welcome

Pantherna Therapeutics is a privately-held biopharmaceutical Company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is based on advanced nanoparticles for the delivery and expression of therapeutic mRNA drugs in the endothelium.

Pantherna is based in Hennigsdorf (Brandenburg) close to Berlin, Germany. 

Latest News

Team

Dr. Klaus Giese
Dr. Klaus GieseCEO
Dr. Gerrit Maass
Dr. Gerrit MaassCFO
Dr. Jörg Kaufmann
Dr. Jörg KaufmannCSO
Dr. Oliver Keil
Dr. Oliver KeilCTO

Contact

Get in touch

Pantherna Therapeutics GmbH
Neuendorfstrasse 20b
D-16761 Hennigsdorf
Germany

Telephone: +49(0)3302-202 240-0
Telefax: +49(0)3302-202 240-1

E-Mail: contact@pantherna-therapeutics.com

Managing Directors: Dr. Klaus Giese, Dr. Jörg Kaufmann, Dr. Gerrit Maass

How can we help?

Please note our Privacy Policy

For privacy reasons Google Maps needs your permission to be loaded.
I Accept

Public Funding

Pantherna is supported by public funding from the EU (EFRE). EFRE is provided by the State Brandenburg  through the following programs “ProFIT and Gründung Innovativ:

#80174940 „Förderung von Forschung, Innovationen und Technologien ProFIT (ab 2014) ProFIT: Zelltyp-spezifische Expression therapeutischer Proteine (AP 1, 2, 3, 4)“

#80174941 „Förderung von Forschung, Innovationen und Technologien ProFIT (ab 2014) ProFIT: Zelltyp-spezifische Expression therapeutischer Proteine (AP 5 und 6)“

#85026035 „Gründung Innovativ 2015 – 2020 Optimierung der Herstellung von mRNA-Konstrukten für die in-vivo Expression von therapeutischen Proteinen i. d. Vaskulation“